A study identified NUAK2 and RCAN2 as differentially regulated genes with concordant prognostic value in human PDAC harboring p53 mutations, suggesting that NUAK2 and RCAN2 are novel candidate genes involved in tumor-promoting networks induced by p53 mutations [24]. Here, RCAN2 is linked to neoplasm.